Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2009C012 Product name: ALGLUCOSIDASE ALFA.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
2009C/012
Type:
Certificate
SPC type:
Medical
Basic patent number:
999651623
Status:
Invalid
Publication number:
2009C012
1rst applicant's nationality:
Procedural language:
French

Marketing authorization

Marketing authorization number:
EU/1/06/333/001
Marketing authorization type:
National/EU
Designates country:
No
Marketing authorization date:
31/03/2006
Marketing authorization status:
Accepted
Marketing authorization country:
Belgium (BE)

Dates

Filing date:
31/03/2009
First marketing authorization date:
31/03/2006
Grant date:
01/09/2009
Activation date:
06/12/2019
Annulment Date:
20/10/2015
BE Publication date:
01/09/2009
Lapsed date:
Expiration date (if granted and all annual fees paid):
Basic SPC Expiration (if granted and all annual fees paid):
31/03/2021
SPC/SPC Extension Expiration (if granted and all annual fees paid):
31/03/2021
Rejection date:
Withdrawal date:

Applicant

Name:
GENZYME CORPORATION.
Legal Form:
From:
31/03/2009
Address:
500 Kendall Street, Cambridge MA 02142, United States (US)
To:

Agent

1

Name:
KIRKPATRICK
Legal Form:
S.A.
From:
15/06/2021
Address:
Avenue Wolfers 32, 1310, LA HULPE, Brabant wallon, Belgium (BE)
To:

2

Name:
VANDEBERG Marie Paule
Legal Form:
From:
31/03/2009
Address:
Avenue Wolfers 32, 1310, LA HULPE, Belgium (BE)
To:
15/06/2021

Publication

Bulletin

1

Bulletin heading:
SPC
Journal edition number:
2009/09
Publication date:
30/09/2009
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates

2

Bulletin heading:
VRV
Journal edition number:
2018/29
Publication date:
07/12/2018
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type
Certificate PDF /2/1/0/9/0/0300009012/migrated-docs/2009CSLASH012_0_2009C012.pdf
23/03/2023 Request For Change Letter and/or Form requesting a change in the Register 1 PDF /2/1/0/9/0/0300009012/docs/2009c012_1_rfc_20230404_080933441.pdf